International Journal of Cancer Management

Published by: Kowsar

Inhibitory Effects of Cichorium Intybus Root Extract on the Proliferation and Lipogenesis of the SKBR3 Cells

Reza Mehrandish 1 , Nasrin Dehghan-Nayeri 2 , Aliasghar Rahimian 1 , Ali Toutounchi 3 and Ali Mellati 1 , *
Authors Information
1 Zanjan Metabolic Diseases Research Center and Biochemistry Department, Zanjan University of Medical Sciences, Zanjan, Iran
2 Proteomics Research Center, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Department of Clinical Biochemistry, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • International Journal of Cancer Management: April 2018, 11 (4); e9436
  • Published Online: April 30, 2018
  • Article Type: Research Article
  • Received: October 22, 2016
  • Revised: April 15, 2017
  • Accepted: February 27, 2018
  • DOI: 10.5812/ijcm.9436

To Cite: Mehrandish R, Dehghan-Nayeri N, Rahimian A, Toutounchi A, Mellati A. Inhibitory Effects of Cichorium Intybus Root Extract on the Proliferation and Lipogenesis of the SKBR3 Cells, Int J Cancer Manag. 2018 ; 11(4):e9436. doi: 10.5812/ijcm.9436.

Abstract
Copyright © 2018, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Tian WX. Inhibition of fatty acid synthase by polyphenols. Curr Med Chem. 2006;13(8):967-77. [PubMed: 16611078].
  • 2. Street RA, Sidana J, Prinsloo G. Cichorium intybus: Traditional Uses, Phytochemistry, Pharmacology, and Toxicology. Evid Based Complement Alternat Med. 2013;2013:579319. doi: 10.1155/2013/579319. [PubMed: 24379887].
  • 3. Berndt J, Kovacs P, Ruschke K, Kloting N, Fasshauer M, Schon MR, et al. Fatty acid synthase gene expression in human adipose tissue: association with obesity and type 2 diabetes. Diabetologia. 2007;50(7):1472-80. doi: 10.1007/s00125-007-0689-x. [PubMed: 17492427].
  • 4. Wakil SJ, Stoops JK, Joshi VC. Fatty acid synthesis and its regulation. Annu Rev Biochem. 1983;52:537-79. doi: 10.1146/annurev.bi.52.070183.002541. [PubMed: 6137188].
  • 5. Vazquez-Martin A, Colomer R, Brunet J, Menendez JA. Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells. Int J Oncol. 2007;31(4):769-76. [PubMed: 17786307].
  • 6. Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11(2):85-95. doi: 10.1038/nrc2981. [PubMed: 21258394].
  • 7. Sugino T, Baba K, Hoshi N, Aikawa K, Yamaguchi O, Suzuki T. Overexpression of fatty acid synthase in human urinary bladder cancer and combined expression of the synthase and Ki-67 as a predictor of prognosis of cancer patients. Med Mol Morphol. 2011;44(3):146-50. doi: 10.1007/s00795-010-0517-0. [PubMed: 21922386].
  • 8. Alo PL, Visca P, Marci A, Mangoni A, Botti C, Di Tondo U. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer. 1996;77(3):474-82. [PubMed: 8630954].
  • 9. Dehghan-Nayeri N, Gharehbaghian A, Goudarzi Pour K, Eshghi P. Over expression of the fatty acid synthase is a strong predictor of poor prognosis and contributes to glucocorticoid resistance in b-cell acute lymphoblastic leukemia. World Canc Res J. 2016;3(3).
  • 10. Chuang HY, Chang YF, Hwang JJ. Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal. Biomed Pharmacother. 2011;65(4):286-92. doi: 10.1016/j.biopha.2011.02.016. [PubMed: 21723078].
  • 11. Brusselmans K, Vrolix R, Verhoeven G, Swinnen JV. Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity. J Biol Chem. 2005;280(7):5636-45. doi: 10.1074/jbc.M408177200. [PubMed: 15533929].
  • 12. Saleem M, Abbas K, Naseer F, Ahmad M, Javed F, Hussain K, et al. Anticancer activity of n-hexane extract of Cichorium intybus on lymphoblastic leukemia cells (Jurkat cells). Afr J Plant Sci. 2014;8(6):315-9.
  • 13. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9). e45. [PubMed: 11328886].
  • 14. Mehrandish R, Mellati AA, Rahimipour A, Dehghan Nayeri N. Anti-Cancer activity of methanol extracts of Cichorium intybus on Human Breast Cancer SKBR3 Cell Line (2016). Razavi Int J Med.
  • 15. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7(10):763-77. doi: 10.1038/nrc2222. [PubMed: 17882277].
  • 16. Fonseca-Alaniz MH, Takada J, Alonso-Vale MI, Lima FB. Adipose tissue as an endocrine organ: from theory to practice. J Pediatr (Rio J). 2007;83(5 Suppl):S192-203. doi: 10.2223/JPED.1709. [PubMed: 17989837].
  • 17. Tavasoli M, Ghaedi K, Tavasoli Z, Sadeghi M. Signal transduction for cancer treatment. Genetics in the Third Millennium. 2007;4(4). Persian.
  • 18. Esmaeilbeig M, Kouhpayeh SA, Amirghofran Z. An Investigation of the Growth Inhibitory Capacity of Several Medicinal Plants From Iran on Tumor Cell Lines. Iran J Cancer Prev. 2015;8(5). e4032. doi: 10.17795/ijcp-4032. [PubMed: 26634114].
  • 19. Gospodinova Z, Krasteva M. Cichorium intybus L. from Bulgaria inhibits viability of human breast cancer cells in vitro. Genet Plant Physiol. 2015;5(1):15-22.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments